Denali Therapeutics Inc. DNLI Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s common stock, shares, outstanding?
- Denali Therapeutics Inc. (DNLI) reported common stock, shares, outstanding of $158.66M in Q1 2026.
- How has Denali Therapeutics Inc.'s common stock, shares, outstanding changed year-over-year?
- Denali Therapeutics Inc.'s common stock, shares, outstanding increased by 9.2% year-over-year, from $145.25M to $158.66M.
- What is the long-term trend for Denali Therapeutics Inc.'s common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s common stock, shares, outstanding has grown at a 5.3% compound annual growth rate (CAGR), from $120.53M to $156.18M.